121 related articles for article (PubMed ID: 22862160)
1. Down-regulation of TCF21 is associated with poor survival in clear cell renal cell carcinoma.
Ye YW; Jiang ZM; Li WH; Li ZS; Han YH; Sun L; Wang Y; Xie J; Liu YC; Zhao J; Tang AF; Li XX; Guan ZC; Gui YT; Cai ZM
Neoplasma; 2012; 59(6):599-605. PubMed ID: 22862160
[TBL] [Abstract][Full Text] [Related]
2. Protein expression and promoter methylation of the candidate biomarker TCF21 in gastric cancer.
Yang Z; Li DM; Xie Q; Dai DQ
J Cancer Res Clin Oncol; 2015 Feb; 141(2):211-20. PubMed ID: 25156819
[TBL] [Abstract][Full Text] [Related]
3. TCF21 hypermethylation regulates renal tumor cell clonogenic proliferation and migration.
Gooskens SL; Klasson TD; Gremmels H; Logister I; Pieters R; Perlman EJ; Giles RH; van den Heuvel-Eibrink MM
Mol Oncol; 2018 Feb; 12(2):166-179. PubMed ID: 29080283
[TBL] [Abstract][Full Text] [Related]
4. miR-21 downregulated TCF21 to inhibit KISS1 in renal cancer.
Zhang H; Guo Y; Shang C; Song Y; Wu B
Urology; 2012 Dec; 80(6):1298-302.e1. PubMed ID: 23206776
[TBL] [Abstract][Full Text] [Related]
5. Down-regulation of human leukocyte antigen class I (HLA-I) is associated with poor prognosis in patients with clear cell renal cell carcinoma.
Yuan J; Liu S; Yu Q; Lin Y; Bi Y; Wang Y; An R
Acta Histochem; 2013 Jun; 115(5):470-4. PubMed ID: 23245688
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-217, down-regulated in clear cell renal cell carcinoma and associated with lower survival, suppresses cell proliferation and migration.
Li H; Zhao J; Zhang JW; Huang QY; Huang JZ; Chi LS; Tang HJ; Liu GQ; Zhu DJ; Ma WM
Neoplasma; 2013; 60(5):511-5. PubMed ID: 23790169
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical analysis with multiple antibodies in search of prognostic markers for clear cell renal cell carcinoma.
Phuoc NB; Ehara H; Gotoh T; Nakano M; Yokoi S; Deguchi T; Hirose Y
Urology; 2007 May; 69(5):843-8. PubMed ID: 17482919
[TBL] [Abstract][Full Text] [Related]
8. PAI-1 expression and its regulation by promoter 4G/5G polymorphism in clear cell renal cell carcinoma.
Choi JW; Lee JH; Park HS; Kim YS
J Clin Pathol; 2011 Oct; 64(10):893-7. PubMed ID: 21725041
[TBL] [Abstract][Full Text] [Related]
9. Clear cell renal cell carcinoma: gene expression analyses identify a potential signature for tumor aggressiveness.
Kosari F; Parker AS; Kube DM; Lohse CM; Leibovich BC; Blute ML; Cheville JC; Vasmatzis G
Clin Cancer Res; 2005 Jul; 11(14):5128-39. PubMed ID: 16033827
[TBL] [Abstract][Full Text] [Related]
10. Frequent epigenetic suppression of tumor suppressor gene glutathione peroxidase 3 by promoter hypermethylation and its clinical implication in clear cell renal cell carcinoma.
Liu Q; Jin J; Ying J; Sun M; Cui Y; Zhang L; Xu B; Fan Y; Zhang Q
Int J Mol Sci; 2015 May; 16(5):10636-49. PubMed ID: 25970749
[TBL] [Abstract][Full Text] [Related]
11. Genetic and epigenetic control of UNC5C expression in human renal cell carcinoma.
Lv D; Zhao W; Dong D; Qian XP; Zhang Y; Tian XJ; Zhang J
Eur J Cancer; 2011 Sep; 47(13):2068-76. PubMed ID: 21600761
[TBL] [Abstract][Full Text] [Related]
12. High-expression of ZBP-89 correlates with distal metastasis and poor prognosis of patients in clear cell renal cell carcinoma.
Cai MY; Luo RZ; Li YH; Dong P; Zhang ZL; Zhou FJ; Chen JW; Yun JP; Zhang CZ; Cao Y
Biochem Biophys Res Commun; 2012 Oct; 426(4):636-42. PubMed ID: 22982674
[TBL] [Abstract][Full Text] [Related]
13. High cytoplasmic expression of p27(Kip1) is associated with a worse cancer-specific survival in clear cell renal cell carcinoma.
Kruck S; Merseburger AS; Hennenlotter J; Scharpf M; Eyrich C; Amend B; Sievert KD; Stenzl A; Bedke J
BJU Int; 2012 May; 109(10):1565-70. PubMed ID: 21981759
[TBL] [Abstract][Full Text] [Related]
14. Down-regulation of TCF21 by hypermethylation induces cell proliferation, migration and invasion in colorectal cancer.
Dai Y; Duan H; Duan C; Zhou R; He Y; Tu Q; Shen L
Biochem Biophys Res Commun; 2016 Jan; 469(3):430-6. PubMed ID: 26435499
[TBL] [Abstract][Full Text] [Related]
15. Osteopontin expression correlates with nuclear factor-κB activation and apoptosis downregulation in clear cell renal cell carcinoma.
Matušan-Ilijaš K; Damante G; Fabbro D; Dorđević G; Hadžisejdić I; Grahovac M; Marić I; Spanjol J; Grahovac B; Jonjić N; Lučin K
Pathol Res Pract; 2011 Feb; 207(2):104-10. PubMed ID: 21167650
[TBL] [Abstract][Full Text] [Related]
16. Lymphangiogenesis in kidney cancer: expression of VEGF-C, VEGF-D and VEGFR-3 in clear cell and papillary renal cell carcinoma.
Bierer S; Herrmann E; Köpke T; Neumann J; Eltze E; Hertle L; Wülfing C
Oncol Rep; 2008 Oct; 20(4):721-5. PubMed ID: 18813809
[TBL] [Abstract][Full Text] [Related]
17. [The expression and clinical significance of Annexin II in clear-cell renal cell carcinoma].
Yang J; Cheng TT; Wang LN; Chen W; Li X
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2012 Jan; 28(1):59-62. PubMed ID: 22230505
[TBL] [Abstract][Full Text] [Related]
18. Proteomic identification of angiomotin by ProteomeLab PF-2D and correlation with clinical outcome in human clear cell renal cell carcinoma.
Yang J; Liu P; Tian M; Li Y; Chen W; Li X
Int J Oncol; 2013 Jun; 42(6):2078-86. PubMed ID: 23588948
[TBL] [Abstract][Full Text] [Related]
19. Phosphorylation of ERK1/2 and prognosis of clear cell renal cell carcinoma.
Lee HJ; Kim DI; Kang GH; Kwak C; Ku JH; Moon KC
Urology; 2009 Feb; 73(2):394-9. PubMed ID: 18849062
[TBL] [Abstract][Full Text] [Related]
20. TCF21 hypermethylation in genetically quiescent clear cell sarcoma of the kidney.
Gooskens SL; Gadd S; Guidry Auvil JM; Gerhard DS; Khan J; Patidar R; Meerzaman D; Chen QR; Hsu CH; Yan C; Nguyen C; Hu Y; Mullighan CG; Ma J; Jennings LJ; de Krijger RR; van den Heuvel-Eibrink MM; Smith MA; Ross N; Gastier-Foster JM; Perlman EJ
Oncotarget; 2015 Jun; 6(18):15828-41. PubMed ID: 26158413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
